Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACC006 plus nab-paclitaxel/carboplatin in advanced squamous NSCLC
CTR20201053Phase 2Completed
- Sponsor
- Aidi Pharma
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ACC006 in Pulmonary squamous cell carcinoma, sponsored by Aidi Pharma. Started Jun 2020; status: completed.
02
Drugs
ACC006
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on CTR20201053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201053.